Emily Cowley Leongini’s Insights

137 total results. Page 4 of 12.

Alerts
FDA Draft Guidance Provides Further Details on New Cosmetic Product Facility Registration and Product Listing Requirements
Health Care Counsel Blog
Access to Mifepristone Hangs in the Balance
Alerts
Tenth Circuit Declares No Remedy for Hemp Farmer Whose Federally Legal Plants Were Seized
Alerts
Modified REMS, Clarification on Mailing Drugs, and Movement in Texas Case Mark Significant Weeks in the Reproductive Health Legal Sphere
Alerts
Consolidated Appropriations Act, 2023 Contains Significant Provisions for Cosmetic Products
Alerts
New Law Eases Federal Restrictions on Medical Marijuana Research and Cultivation
Health Care Counsel Blog
New Challenge to Abortion Access Takes on FDA Drug Approvals
News
Golden and Leongini Quoted on FDA Information Request in Country’s First OTC Daily Oral Contraceptive
News
Leongini and Golden Quoted on Potential Effects of Dobbs v. Jackson on Contraceptive Access
Press Release
ArentFox Schiff Attorneys Recognized by Best Lawyers and Ones to Watch for 2023
Press Release
ArentFox Schiff Advises Altaris Capital Partners, LLC on Acquisition of Intricon Corporation
Alerts
DCC Signals Big Changes to California Cannabis Regulation